Overexpression of Thioredoxin Reductase 1 Regulates NF-κB Activation

Journal of Cellular Physiology

Volumn 198, Issue 1, 2004, Pages 22-30

  Sakurai, Atsuko ^a,b   Yuasa, Kouji ^a   Shoji, Yasuko ^a   Himeno, Seiichiro ^a   Tsujimoto, Masafumi ^b   Kunimoto, Manabu ^a   Imura, Nobumasa ^a   Hara, Shuntaro ^a  

^a KITASATO UNIVERSITY   (Japan)

^b INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FLAVOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SELENOCYSTEINE; THIOREDOXIN REDUCTASE; THIOREDOXIN REDUCTASE 1; THIOREDOXIN REDUCTASE 2; THIOREDOXIN REDUCTASE 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CONTROLLED STUDY; DNA BINDING; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE OVEREXPRESSION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIRHEUMATIC AGENTS; CATTLE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; GOLD SODIUM THIOMALATE; HUMANS; ISOENZYMES; LIVER; MICE; NF-KAPPA B; THIOREDOXIN REDUCTASE (NADPH); TUMOR NECROSIS FACTOR-ALPHA;

EID: 1642474377     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10377     Document Type: Article

References (39)

1. Becker K, Gromer S, Schirmer RH, Müller S. 2000. Thioredoxin reductase as a pathophysiological factor and drug target. Eur J Biochem 267:6118-6125.
2. Bondeson J. 1997. The mechanisms of action of disease-modifying antirheumatic drugs: A review with emphasis on macrophage signal transduction and the induction of proinflammatory cytokines. Gen Pharmacol 29:127-150.
3. Bowie A, O'Neill LAJ. 2000. Oxidative stress and nuclear factor-κB activation. Biochem Pharmacol 59:13-23.
4. Brennan P, O'Neill LA. 1995. Effects of oxidants and antioxidants on nuclear factor kappa B activation in three different cell lines: Evidence against a universal hypothesis involving oxygen radicals. Biochim Biophys Acta 1260:167-175.
5. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
6. Fujiwara N, Fujii T, Fujii J, Taniguchi N. 1999. Functional expres-sion of rat thioredoxin reductase: Selenocysteine insertion sequence element is essential for the active enzyme. Biochem J 340:439-444.
7. Fujiwara N, Fujii T, Fujii J, Taniguchi N. 2001. Roles of N-terminal active cysteines and C-terminal cysteine-selenocysteine in the catalytic mechanism of mammalian thioredoxin reductase. J Biochem 129:803-812.
8. Gasdaska JR, Harney JW, Gasdaska PY, Powis G, Berry MJ. 1999. Regulation of human thioredoxin reductase expression and activity by 3′-untranslated region selenocysteine insertion sequence and mRNA instability elements. J Biol Chem 274:25379-25385.
9. Ghosh S, May MJ, Kopp EB. 1998. NF-κB and rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16:225-260.
10. Hara S, Shoji Y, Sakurai A, Yuasa K, Himeno S, Imura N. 2001. Effects of selenium deficiency on expression of selenoproteins in bovine arterial endothelial cells. Biol Pharm Bull 24:754-759.
11. Hill KE, McCollum GW, Burk RF. 1997. Determination of thioredoxin reductase activity in rat liver supernatant. Anal Biochem 253:123-125.
12. Hirota K, Murata M, Sachi Y, Nakamura H, Takeuchi J, Mori K, Yodoi J. 1999. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. J Biol Chem 274:27891-27897.
13. Howie AF, Arthur JR, Nicol F, Walker SW, Beech SG, Beckett GJ. 1998. Identification of a 57-kilodalton selenoprotein in human thyrocytes as thioredoxin reductase and evidence that its expression is regulated through the calcium-phosphoinositol signaling pathway. J Clin Endocrinol Metab 83:2052-2058.
14. Karimpour S, Lou J, Lin LL, Rene LM, Lagunas L, Ma X, Karra S, Bradbury CM, Markovina S, Goswami PC, Spitz DR, Hirota K, Kalvakolanu DV, Yodoi J, Gius D. 2002. Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation. Oncogene 21:6317-6327.
15. Karin M, Delhase M. 2000. The IκB kinase and NF-κB: Key elements of proinflammatory signaling. Semin Immunol 12:85-98.
16. Kawai H, Ota T, Suzuki F, Tatsuka M. 2000. Molecular cloning of mouse thioredoxin reductases. Gene 242:321-330.
17. Koishi R, Kawashima I, Yoshimura C, Sugawara M, Serizawa N. 1997. Cloning and characterization of a novel oxidoreductase KDRF from a human bone marrow-derived stromal cell line KM-102. J Biol Chem 272:2570-2577.
18. Kosaka T, Miyata A, Ihara H, Hara S, Sugimoto T, Takeda O, Takahashi E, Tanabe T. 1994. Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase-2. Eur J Biochem 221:889-897.
19. Kretz-Remy C, Mehlen P, Mirault ME, Arrigo AP. 1996. Inhibition of IκB-α phosphorylation and degradation and subsequent NF-κB activation by glutathione peroxidase overexpression. J Cell Biol 133:1083-1093.
20. Manna SK, Zhang HJ, Yan T, Oberley LW, Aggarwal BB. 1998. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-κB and activated protein-1. J Biol Chem 273:13245-13254.
21. Masuda M, Fujiwara K. 1993. The biased lamellipodium development and microtubule organizing center position in vascular endothelial cells migrating under the influence of fluid flow. Biol Cell 77:237-245.
22. Matthews JR, Wakasugi N, Virelizier JL, Yodoi J, Hay RT. 1992. Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res 20:3821-3830.
23. Maurice MM, Nakamura H, Gringhuis S, Okamoto T, Yoshida S, Kullmann F, Lechner S, van der Voort EA, Leow A, Versendaal J, Muller-Ladner U, Yodoi J, Tak PP, Breedveld FC, Verweij CL. 1999. Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum 42:2430-2439.
24. May MJ, Ghosh S. 1998. Signal transduction through NF-κB, Immunol Today 19:80-88.
25. Mustacich D, Powis G. 2000. Thioredoxin reductase. Biochem J 346:1-8.
26. Nakamura H, Nakamura K, Yodoi J. 1997. Redox regulation of cellular activation. Annu Rev Immunol 15:351-369.
27. Nguyen M, Strubel NA, Bischoff J. 1993. A role for sialyl-Lewis-X/A glycoconjugates in capillary morphogenesis. Nature 365:267-269.
28. Nordberg J, Arnér ESJ. 2001. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 31:1287-1312.
29. Osborne SA, Tonissen KF. 2001. Genomic organization and alternative splicing of mouse and human thioredoxin reductase 1 genes. BMC Genomics 2:10-17.
30. Powis G, Montfort WR. 2001. Properties and biological activities of thioredoxins. Annu Rev Pharmacol Toxicol 41:261-295.
31. Read MA, Whitley MZ, Gupta S, Pierce JW, Best J, Davis RJ, Collins T. 1997. Tumor necrosis factor α-induced E-selectin expression is activated by the nuclear factor-κB and c-Jun N-terminal kinase/p38 mitogen-activated kinase pathways. J Biol Chem 272:2753-2761.
32. Rundlöf AK, Carlsten M, Arnér ESJ. 2001. The core promoter of human thioredoxin reductase 1. J Biol Chem 276:30542-30551.
33. Sakurai A, Hara S, Okano N, Kondo Y, Inoue J, Imura N. 1999, Regulatory role of metallothionein in NF-κB activation. FEBS Lett 455:55-58.
34. Schenk H, Klein M, Erdbrügger W, Dröge W, Schulze-Osthoff K. 1994. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP-1. Proc Natl Acad Sci USA 91:1672-1676.
35. Sun QA, Wu Y, Zappacosta F, Jeang KT, Lee BJ, Hatfield DL, Gladyshev VN. 1999. Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductase. J Biol Chem 274:24522-24530.
36. Sun QA, Kirnarsky L, Sherman S, Gladyshev VN. 2001. Selenoprotein oxidoreductase with specificity for thioredoxin and glutathione systems. Proc Natl Acad Sci USA 98:3673-3678.
37. Tolando R, Jovanović A, Brigelius-Flohé R, Ursini F, Maiorino M. 2000. Reactive oxygen species and proinflammatory cytokine signaling in endothelial cells: Effect of selenium supplementation. Free Radic Biol Med 28:979-986.
38. Winzen R, Kracht M, Ritter B, Wilhelm A, Chen CYA, Shyu AB, Müller M, Gaestel M, Resch K, Holtmann H, 1999. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J 18:4969-4980.
39. Yamamoto K, Arakawa T, Ueda N, Yamamoto S. 1995. Transcriptional roles of nuclear factor κB and nuclear factor-interleukin-6 in the tumor necrosis factor α-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J Biol Chem 270:31315-31320.